<DOC>
	<DOCNO>NCT00613782</DOCNO>
	<brief_summary>In men type 2 diabetes , low testosterone level associate insulin resistance , truncal obesity symptom fatigue erectile dysfunction . Low testosterone may impair cardiac function increase cardiovascular risk cause osteoporosis . The goal project ass prospectively whether , men type 2 diabetes mellitus low testosterone level , testosterone replacement improve insulin resistance , body composition , bone density , cardiac function symptom associate low testosterone level . The investigator recruit 140 ambulatory men type 2 diabetes low serum testosterone level ( &lt; 10 nmol/L ) Austin Health Endocrine clinic , General Practise surgery , general public direct consumer advertising via newspaper local medium . Men randomise either intramuscular testosterone undecanoate ( Reandron 1000 , Bayer Schering Pharma ) placebo . Men contraindication testosterone replacement intramuscular injection exclude study . All men receive intramuscular testosterone placebo injection 0 , 6 , 18 30 week ( total four injection ) . All 140 study subject clinical laboratory assessment baseline , 18 week study end ( 40 week ) . All 140 subject also image study baseline study end ( 40 week ) . The study protocol outline detail : Clinical laboratory assessment ( Baseline repeat 18 week , 40 week ) A full medical history physical examination perform . Symptoms assess follow standardised questionnaire : 1 ) Androgen Deficiency Aging Male ( ADAM ) ; 2 ) Aging Male Symptom scale ( AMS ) ; 3 ) International Index Erectile Dysfunction ( IIED ) ; 4 ) International Prostate Symptom Score ( IPSS ) ; 5 ) SF-36 ( five questionnaire attach Module 1 ) . Laboratory study consist blood test measure total testosterone , fast glucose , C-peptide , HBA1c routine parameter . Imaging study ( Baseline repeat 40 week ) 1 . Body composition bone mineral density DEXA 2 . Body composition magnetic resonance image 3 . Bony micro-architecture high resolution quantitative compute tomography [ HR-pQCT ] ) , 4 . Cardiac dimension function transthoracic doppler echocardiography</brief_summary>
	<brief_title>Reandron Diabetic Men Witn Low Testosterone Level</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Type 2 diabetes Testosterone le 10 nmol/L Contraindication Testosterone IM injection</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>